- Home
- FMST vs CASI Comparison
FMST vs CASI Comparison
Compare FMST & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMST
- CASI
- Stock Information
- Founded
- FMST 2005
- CASI 1991
- Country
- FMST Canada
- CASI China
- Employees
- FMST N/A
- CASI N/A
- Industry
- FMST Other Metals and Minerals
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- FMST Basic Materials
- CASI Health Care
- Exchange
- FMST Nasdaq
- CASI Nasdaq
- Market Cap
- FMST 38.2M
- CASI 35.8M
- IPO Year
- FMST N/A
- CASI 1996
- Fundamental
- Price
- FMST $2.97
- CASI $2.02
- Analyst Decision
- FMST
- CASI Strong Buy
- Analyst Count
- FMST 0
- CASI 1
- Target Price
- FMST N/A
- CASI $4.00
- AVG Volume (30 Days)
- FMST 370.8K
- CASI 76.1K
- Earning Date
- FMST 08-13-2025
- CASI 11-13-2025
- Dividend Yield
- FMST N/A
- CASI N/A
- EPS Growth
- FMST N/A
- CASI N/A
- EPS
- FMST N/A
- CASI N/A
- Revenue
- FMST N/A
- CASI $31,564,000.00
- Revenue This Year
- FMST N/A
- CASI N/A
- Revenue Next Year
- FMST N/A
- CASI N/A
- P/E Ratio
- FMST N/A
- CASI N/A
- Revenue Growth
- FMST N/A
- CASI 36.64
- 52 Week Low
- FMST $0.55
- CASI $1.09
- 52 Week High
- FMST $5.74
- CASI $7.50
- Technical
- Relative Strength Index (RSI)
- FMST 49.40
- CASI 44.31
- Support Level
- FMST $2.80
- CASI $2.18
- Resistance Level
- FMST $3.06
- CASI $2.49
- Average True Range (ATR)
- FMST 0.24
- CASI 0.18
- MACD
- FMST -0.03
- CASI -0.06
- Stochastic Oscillator
- FMST 21.76
- CASI 1.02
About FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.